Grégory Fenaux

机构：Innate Pharma (France)

发表论文 4 篇 · 总被引 54 次 · h-index 2

代表论文

• Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer’s Disease (2020 · Journal of Alzheimer s Disease · 被引 51)
• Abstract 6582: Preclinical characterization of IPH45, a novel topoisomerase I inhibitor ADC targeting Nectin-4 for the treatment of Nectin-4 expressing tumors (2024 · Cancer Research · 被引 2)
• Abstract 5443: IPH4502, a differentiated Nectin-4 exatecan antibody-drug conjugate (2025 · Cancer Research · 被引 1)
• 1056 IPH45, a next-generation antibody-drug conjugate (ADC) targeting nectin-4 (2024 · Regular and Young Investigator Award Abstracts)